Exhibit 10.1


 


IDEAL POWER INC.


 


July 31,
2020


 


Holder of Series A Common Stock Purchase
Warrant


 


		Re:	Inducement Offer to Exercise Common Stock Purchase
Warrants



 


Dear Holder:


 


Ideal Power Inc. (the
“Company”) is pleased to offer to you the opportunity to exercise all of the Series A Common Stock Purchase
Warrants set forth on the signature page hereto (the “Existing Warrants”) currently held by you (the “Holder”).
The Existing Warrants and the shares of Common Stock underlying the Existing Warrants (“Warrant Shares”) have
been registered for resale pursuant to registration statement Form S-3 (File No. 333-235500) (the “Registration
Statement”). The Registration Statement is currently effective and, upon exercise of the Existing Warrants pursuant to
this letter agreement, will be effective for the issuance or sale, as the case may be, of the Warrant Shares. Capitalized terms
not otherwise defined herein shall have the meanings set forth in the Existing Warrant and the Securities Purchase Agreement, dated
as of November 7, 2019 by and among the Company and the purchasers signatory thereto.


 


In
consideration for exercising in full all of the Existing Warrants held by you and set forth on the signature page hereto (the
“Warrant Exercise”) at the existing exercise price of $2.32 per share, the Company hereby offers to issue you
or your designee a Series C Common Stock Purchase Warrant (“New Warrant”) pursuant to Section 4(a)(2) of
the Securities Act of 1933, as amended (“Securities Act”), to purchase up to a number of shares of Common Stock
equal to 60% of the number of Warrant Shares issued pursuant to the Warrant Exercise hereunder, which New Warrant shall
be substantially in the form of the Existing Warrants, will be exercisable immediately, have a term of exercise of 60 months, and
an exercise price equal to $8.90 per share. The original New Warrant certificate(s) will be delivered within two Business
Days following the date hereof. Notwithstanding anything to the contrary, in the event the Warrant Exercise would otherwise cause
the Holder to exceed the beneficial ownership limitations (“Beneficial Ownership Limitation”) set forth in Section 2(e) of
the Existing Warrants, the Company shall only issue such number of Warrant Shares to the Holder that would not cause the Holder
to exceed the maximum number of Warrant Shares permitted thereunder with the balance to be held in abeyance until notice from the
Holder that the balance (or portion thereof) may be issued in compliance with such limitations, which abeyance shall be evidenced
through the Existing Warrant which shall be deemed prepaid thereafter, and exercised pursuant to a Notice of Exercise in the Existing
Warrant (provided no additional exercise price shall be payable). For purposes of clarification,
the exercise of the Warrant Shares held in abeyance shall be governed by the terms and conditions of the Existing Warrants,
including but not limited to the Company’s obligations set forth in Section 2(d) of the Existing Warrant. Notwithstanding
the foregoing, in the event that the Holder has not received all of its Warrant Shares held in abeyance on or before the Termination
Date of the Existing Warrants, the obligations to deliver the Warrant Shares shall extend until the earlier of (i) such time
that the Holder has received all Warrant Shares then held in abeyance and (ii) May 12, 2025.


 


Expressly subject to
the paragraph immediately following this paragraph below, the Holder may accept this offer by signing this letter below, with such
acceptance constituting Holder's exercise in full of the Existing Warrants for an aggregate exercise price set forth on the Holder’s
signature page hereto (the “Warrants Exercise Price”) on or before 9:00 a.m. Eastern on August 3,
2020.


 






     

     


    

 


The Company shall use
reasonable best efforts maintain the effectiveness of the Registration Statement until such time that the Warrant Shares (i) have
been sold, thereunder or pursuant to Rule 144, or (ii) may be sold without volume or manner-of-sale restrictions pursuant
to Rule 144 and without the requirement for the Company to be in compliance with the current public information requirement
under Rule 144, as determined by the counsel to the Company pursuant to a written opinion letter to such effect, addressed
and acceptable to the Transfer Agent.


 


Additionally, the Company
agrees to the representations, warranties and covenants set forth on Annex A attached hereto. Holder represents and warrants
that it is an “accredited investor” as defined in Rule 501 of the Securities Act, and agrees that the New Warrants
will contain restrictive legends when issued, and neither the New Warrants nor the shares of Common Stock issuable upon exercise
of the New Warrants will be registered under the Securities Act, except in the discretion of the Company.


 


The Holder understands that the New Warrants and the shares of Common Stock underlying New Warrants are not, and may never be, registered under the Securities Act, or the securities laws of any state and, accordingly, each certificate, if any, representing such securities shall bear a legend substantially similar to the following:  



 


“THIS
SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE
UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY,
MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO
AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED
BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE 501(a) UNDER
THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.”


 


Certificates evidencing
shares of Common Stock underlying the New Warrants shall not contain any legend (including the legend set forth above), (i) while
a registration statement covering the resale of such Common Stock is effective under the Securities Act, (ii) following any
sale of such Common Stock pursuant to Rule 144 under the Securities Act, (iii) if such Common Stock is eligible for
sale under Rule 144, without the requirement for the Company to be in compliance with the current public information required
under Rule 144 as to such Common Stock and without volume or manner-of-sale restrictions, (iv) if such Common Stock
may be sold under Rule 144 and the Company is then in compliance with the current public information required under Rule 144
as to such Common Stock, or (v) if such legend is not required under applicable requirements of the Securities Act (including
judicial interpretations and pronouncements issued by the staff of the Securities and Exchange Commission (the “Commission”)
and the earliest of clauses (i) through (v), the “Delegend Date”)). The Company shall cause its counsel
to issue a legal opinion to the Transfer Agent promptly after the Delegend Date if required by the Company and/or the transfer
agent to effect the removal of the legend hereunder, which opinion shall be in form and substance reasonably acceptable to the
Transfer Agent. If such Common Stock may be sold under Rule 144 without the requirement for the Company to be in compliance
with the current public information required under Rule 144 or if such legend is not otherwise required under applicable
requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission)
then such Common Stock shall be issued free of all legends. The Company agrees that following the Delegend Date or at such time
as such legend is no longer required under this Inducement Offer, it will, no later than two (2) Trading Days following the
delivery by the Holder to the Company or the transfer agent of a certificate representing the Common Stock underlying the New
Warrants issued with a restrictive legend (such second Trading Day, the “Legend Removal Date”), deliver or
cause to be delivered to the Holder a certificate representing such shares that is free from all restrictive and other legends
or, at the request of the Holder shall credit the account of the Holder’s prime broker with the Depository Trust Company
System as directed by the Holder. 


 






     

     


    

 


In addition to the Holder’s other available remedies, the Company shall pay to
a Holder, in cash, (i) as partial liquidated damages and not as a penalty, for each $1,000 of Shares or Warrant Shares (based
on the VWAP of the Common Stock on the date such Warrant Shares are submitted to the Transfer Agent) delivered for removal of
the restrictive legend, $10 per Trading Day (increasing to $20 per Trading Day five (5) Trading Days after such damages have
begun to accrue) for each Trading Day after the Legend Removal Date until such certificate is delivered without a legend and (ii) if
the Company fails to (a) issue and deliver (or cause to be delivered) to the Holder by the Legend Removal Date a certificate
representing the Securities so delivered to the Company by the Holder that is free from all restrictive and other legends and
(b) if after the Legend Removal Date the Holder purchases (in an open market transaction or otherwise) shares of Common Stock
to deliver in satisfaction of a sale by the Holder of all or any portion of the number of shares of Common Stock, or a sale of
a number of shares of Common Stock equal to all or any portion of the number of shares of Common Stock that the Holder anticipated
receiving from the Company without any restrictive legend, then, an amount equal to the excess of the Holder’s total purchase
price (including brokerage commissions and other out-of-pocket expenses, if any) for the shares of Common Stock so purchased (including
brokerage commissions and other out-of-pocket expenses, if any) (the “Buy-In Price”) over the product of (A) such
number of Warrant Shares that the Company was required to deliver to the Holder by the Legend Removal Date multiplied by (B) the
lowest closing sale price of the Common Stock on any Trading Day during the period commencing on the date of the delivery by the
Holder to the Company of the applicable Warrant Shares (as the case may be) and ending on the date of such delivery and payment
under this clause (ii).  


 


From the date hereof
until the end of the 90th calendar day following the date hereof (the “Standstill Period”), neither
the Company nor any subsidiary of the Company (the Company acknowledging that it does not currently have any subsidiaries) shall
issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or any securities
of the Company or any subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including, without
limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable
or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock, other than (i) the offer and issuance
of New Warrants to Other Holders (defined below), (ii) shares of Common Stock or any securities (including without limitation
options, restricted stock or restricted stock units) convertible into, or exercisable for, shares of Common Stock pursuant to any
employee stock option plan, incentive plan, stock plan, dividend reinvestment plan or otherwise in equity compensation arrangements
in place as of the date hereof, (iii) the grant of awards pursuant to employee stock option plan or arrangements in place
as of the date hereof, (iv) the filing of a registration statement on Form S-8 in connection with the registration of
shares of Common Stock issuable under any employee performance incentive plan adopted and approved by the Company’s board
of directors, (v) issuance of Common Stock upon exercise or conversion of any securities of the Company outstanding on the
date hereof, and (vi) securities issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested
directors of the Company, provided that such securities are issued as “restricted securities” (as defined in Rule 144)
and carry no registration rights that require or permit the filing of any registration statement in connection therewith during
the Standstill Period, and provided that any such issuance shall only be to a Person (or to the equityholders of a Person) which
is, itself or through its subsidiaries, an operating company or an owner of an asset in a business synergistic with the business
of the Company and shall provide to the Company additional benefits in addition to the investment of funds, but shall not include
a transaction in which the Company is issuing securities primarily for the purpose of raising capital or to an entity whose primary
business is investing in securities.


 






     

     


    

 


As soon as practicable
(and in any event within 30 calendar days of the date of this letter agreement), the Company shall file a registration statement
on Form S-3 (or other appropriate form if the Company is not then S-3 eligible) providing for the resale by the Purchasers
of the New Warrant Shares issued and issuable upon exercise of the New Warrants.  The Company shall use commercially reasonable
efforts to cause such registration to become effective within 90 days following the date of this letter agreement and to keep such
registration statement effective at all times until no Purchaser owns any New Warrants or Warrant Shares underlying the New Warrants
issuable upon exercise thereof.


 


If this offer is accepted
and the transaction documents are executed on or before 9:00 a.m. Eastern on August 3, 2020, then on or before 9:30 am
ET on August 3, 2020, the Company shall file a Current Report on Form 8-K with the SEC disclosing all material terms
of the transactions contemplated hereunder (the “8-K Filing”). From and after the issuance of the 8-K Filing,
the Company represents to the Holder that it shall have publicly disclosed all material, non-public information delivered to the
Holder by the Company or any of its officers, directors, employees or agents in connection with the transactions contemplated hereby.
In addition, effective upon the issuance of the 8-K Filing, the Company acknowledges and agrees that any and all confidentiality
or similar obligations under any agreement, whether written or oral, between the Company or any of its officers, directors, agents,
employees or Affiliates on the one hand, and the Holder or any of its Affiliates on the other hand, shall terminate. From and after
the issuance of the 8-K Filing, the Company represents to the Holder that none of the Company’s directors, officers, employees
or agents will provide the Holder with any material, nonpublic information that is not disclosed in the 8-K Filing.


 


The Company represents,
warrants and covenants that, upon acceptance of this offer, the shares of Common Stock underlying the Existing Warrants shall be
issued free of any legends or restrictions on resale by Holder and all of the Warrant Shares shall be delivered electronically
through the Depository Trust Company within 1 (one) Business Day of the date the Company receives the Warrants Exercise Price (or,
with respect to Warrant Shares that would otherwise be in excess of the Beneficial Ownership Limitation, within 2 (two) Business
Days of the date the Company is notified by Holder that its ownership is less than the Beneficial Ownership Limitation). The terms
of the Existing Warrants, including but not limited to the obligations to deliver the Warrant Shares, shall otherwise remain in
effect as if the acceptance of this offer were a formal Notice of Exercise (including but not limited to any liquidated damages
and compensation in the event of late delivery of the Warrant Shares).


 


The Company acknowledges
and agrees that the obligations of the Holders under this letter agreement are several and not joint with the obligations of any
other holder or any other holders of Warrants to Purchase Common Stock of the Company (each, an “Other Holder”)
under any other agreement related to the exercise of such warrants (“Other Warrant Exercise Agreement”), and
the Holder shall not be responsible in any way for the performance of the obligations of any Other Holder or under any such Other
Warrant Exercise Agreement. Nothing contained in this letter agreement, and no action taken by the Holders pursuant hereto, shall
be deemed to constitute the Holder and the Other Holders as a partnership, an association, a joint venture or any other kind of
entity, or create a presumption that the Holder and the Other Holders are in any way acting in concert or as a group with respect
to such obligations or the transactions contemplated by this letter agreement and the Company acknowledges that the Holder and
the Other Holders are not acting in concert or as a group with respect to such obligations or the transactions contemplated by
this letter agreement or any Other Warrant Exercise Agreement. The Company and the Holder confirm that the Holder has independently
participated in the negotiation of the transactions contemplated hereby with the advice of its own counsel and advisors. The Holder
shall be entitled to independently protect and enforce its rights, including, without limitation, the rights arising out of this
letter agreement, and it shall not be necessary for any Other Holder to be joined as an additional party in any proceeding for
such purpose.


 






     

     


    

 


The
Company hereby represents and warrants as of the date hereof and covenants and agrees from and after the date hereof until 10 (ten)
Trading Days after the date hereof, that none of the terms offered to any Other Holder with respect to any Other Warrant Exercise
Agreement (or any amendment, modification or waiver thereof), is or will be more favorable to such Other Holder than those of the
Holder and this letter agreement. If, and whenever on or after the date hereof until 10 Trading Days after the date hereof, the
Company enters into an Other Warrant Exercise Agreement, then (i) the Company shall provide notice thereof to the Holder promptly
following the occurrence thereof and (ii) the terms and conditions of this letter agreement shall be, without any further
action by the Holder or the Company, automatically amended and modified in an economically and legally equivalent manner such that
the Holder shall receive the benefit of the more favorable terms and/or conditions (as the case may be) set forth in such Other
Warrant Exercise Agreement (including the issuance of additional Warrant Shares), provided that upon written notice to the Company
at any time the Holder may elect not to accept the benefit of any such amended or modified term or condition, in which event the
term or condition contained in this letter agreement shall apply to the Holder as it was in effect immediately prior to such amendment
or modification as if such amendment or modification never occurred with respect to the Holder. The provisions of this paragraph
shall apply similarly and equally to each Other Warrant Exercise Agreement.


 


Each party shall pay
the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such
party incident to the negotiation, preparation, execution, delivery and performance of this letter agreement. The Company shall
pay all transfer agent fees, stamp taxes and other taxes and duties levied in connection with the delivery of any Existing Warrant
Shares. This letter agreement shall be governed by the laws of the State of New York without regard to the principles of conflicts
of law thereof.


 


***************


 






     

     


    

 


Within one business
day from the Holder’s execution of this letter, the Holder shall make available for “Delivery Versus Payment”
to the Company immediately available funds equal to the number of Existing Warrants being exercised multiplied by $2.32 per share
and the Company shall deliver the Warrant Shares via “Delivery Versus Payment” to the Holder and shall deliver the
New Warrants to purchase up to __________ shares of Common Stock registered in the name of the Holder.


 


To accept this offer,
Holder must counter execute this letter agreement and return the fully executed agreement to the Company by e-mail at: tim.burns@idealpower.com
and with a copy to NPrusse@perkinscoie.com, on or before 9 a.m. Eastern on August 3, 2020.


 


Please do not hesitate
to call me if you have any questions.


 


	 	Sincerely yours,
	 	 
	 	IDEAL POWER INC.
	 	 
	 	 
	 	By:  	                                       
	 	Name:
	 	Title:




 


Accepted and Agreed to:


 


Name of Holder: ________________________________________________________


 


Signature
of Authorized Signatory of Holder: _________________________________


 


Name of Authorized Signatory: _______________________________________________


 


Title of Authorized Signatory: ________________________________________________


 


Existing Warrant Shares: ______________


 


Aggregate Exercise Price: _____________


 


New Warrants: (____% of total Series A
Warrants being exercised): ___________


 


DTC Instructions:


 






     

     


    

 


Annex A


 


Representations,
Warranties and Covenants of the Company. The Company hereby makes the following representations and warranties to the
Holder:


 


(a)            Affirmation
of Prior Representations, Warranties and Covenants. The Company hereby represents and warrants to the Holder that the Company’s
representations and warranties as set forth in Section 3 and the Company’s covenants listed in Section 4 of that
certain securities purchase agreement, dated November 7, 2019, by and among the Company and the purchasers signatory thereto
(the “Purchase Agreement”), together with any updates in the Company’s public reports filed with the SEC
subsequent to the Purchase Agreement, are true and correct as of the date hereof and have been fully performed as of the date hereof.


 


(b)            Authorization;
Enforcement. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
by this letter agreement and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of this
letter agreement by the Company and the consummation by the Company of the transactions contemplated hereby have been duly authorized
by all necessary action on the part of the Company and no further action is required by the Company, its board of directors or
its stockholders in connection therewith. This letter agreement has been duly executed by the Company and, when delivered in accordance
with the terms hereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance
with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization,
moratorium and other laws of general application affecting enforcement of creditors’ rights generally, (ii) as limited
by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar
as indemnification and contribution provisions may be limited by applicable law.


 


(c)            No
Conflicts. The execution, delivery and performance of this letter agreement by the Company and the consummation by the Company
of the transactions contemplated hereby do not and will not: (i) conflict with or violate any provision of the Company’s
certificate or articles of incorporation, bylaws or other organizational or charter documents; or (ii) conflict with, or constitute
a default (or an event that with notice or lapse of time or both would become a default) under, result in the creation of any  liens,
claims, security interests, other encumbrances or defects upon any of the properties or assets of the Company in connection with,
or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or
both) of, any material agreement, credit facility, debt or other material instrument (evidencing Company debt or otherwise) or
other material understanding to which such Company is a party or by which any property or asset of the Company is bound or affected;
or (iii) conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other
restriction of any court or governmental authority to which the Company is subject (including federal and state securities laws
and regulations), or by which any property or asset of the Company is bound or affected, except, in the case of each of clauses
(ii) and (iii), such as could not have or reasonably be expected to result in a material adverse effect upon the business,
prospects, properties, operations, condition (financial or otherwise) or results of operations of the Company, taken as a whole,
or in its ability to perform its obligations under this letter agreement.


 


(d)            Nasdaq
Corporate Governance. Subject to filing of Listing of Additional Shares Notification with the Nasdaq Capital Market, the transactions
contemplated under this letter agreement, comply with all rules of the Nasdaq Capital Market.